BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10808249)

  • 1. Radioimmunoassay for hypocretin-2.
    Mitsuma T; Hirooka Y; Kayma M; Mori Y; Yokoi Y; Izumi M; Rhue N; Ping J; Adachi K; Ikai R; Kawai N; Nakayashiki A; Nogimori T
    Endocr Regul; 2000 Mar; 34(1):23-7. PubMed ID: 10808249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for aquaporin-9.
    Li C; Hirooka Y; Yasaka T; Takagi J; Gotoh M; Nogimori T
    Endocr Regul; 2004 Dec; 38(4):157-60. PubMed ID: 15841795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for Aquaporin-2.
    Mitsuma T; Takagi J; Otake K; Kayama M; Mori Y; Adachi K; Nogimori T; Hirooka Y
    Endocr Regul; 1998 Sep; 32(3):141-144. PubMed ID: 10196511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay for somatostatin receptor type 2.
    Hirooka Y; Tagaki J; Ikai R; Kawai H; Nakamura R; Nakayashiki A; Habu S; Otake K; Mori Y; Gotoh M; Nogimori T
    Endocr Regul; 2001 Mar; 35(1):31-4. PubMed ID: 11308994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for thyrotropin-releasing hormone precursor peptide, Lys-Arg-Gln-His-Pro-Gly-Arg-Arg.
    Mitsuma T; Hirooka Y; Nogimori T; Senda Y
    Exp Clin Endocrinol; 1989 Apr; 93(1):53-60. PubMed ID: 2500352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for orexin A.
    Mitsuma T; Hirooka Y; Kayama M; Mori Y; Yokoi Y; Rhue N; Ping J; Izumi M; Ikai R; Adachi K; Nogimori T
    Life Sci; 2000; 66(10):897-904. PubMed ID: 10714890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress.
    Baldo BA; Daniel RA; Berridge CW; Kelley AE
    J Comp Neurol; 2003 Sep; 464(2):220-37. PubMed ID: 12898614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL; Storm E; Bonci A
    Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of FOS in hypocretin neurons of the rat by insulin-induced hypoglycemia.
    Kiss A; Jezova D; Mikkelsen JD
    Endocr Regul; 2004 Sep; 38(3):97-102. PubMed ID: 15693287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilization induced fos expression in the medial and lateral hypothalamic areas: a limited response of hypocretin neurons.
    Kiss A
    Ideggyogy Sz; 2007 Mar; 60(3-4):192-5. PubMed ID: 17451067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-localization of hypocretin-1 and hypocretin-2 in the cat hypothalamus and brainstem.
    Zhang JH; Sampogna S; Morales FR; Chase MH
    Peptides; 2002 Aug; 23(8):1479-83. PubMed ID: 12182950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and genesis of the RFRP-producing neurons in the rat brain: comparison with melanin-concentrating hormone- and hypocretin-containing neurons.
    Legagneux K; Bernard-Franchi G; Poncet F; La Roche A; Colard C; Fellmann D; Pralong F; Risold PY
    Neuropeptides; 2009 Feb; 43(1):13-9. PubMed ID: 19101033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional opioid pathways are necessary for hypocretin-1 (orexin-A)-induced feeding.
    Sweet DC; Levine AS; Kotz CM
    Peptides; 2004 Feb; 25(2):307-14. PubMed ID: 15063013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of aquaporin-9 in the rat: an immunohistochemical study.
    Li C; Hirooka Y; Honda R; Morikawa R; Yatoh M; Gotoh M; Nogimori T
    Int J Tissue React; 2005; 27(2):51-8. PubMed ID: 16035648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum.
    Kohlmeier KA; Inoue T; Leonard CS
    J Neurophysiol; 2004 Jul; 92(1):221-35. PubMed ID: 14999052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices.
    Bayer L; Eggermann E; Serafin M; Grivel J; Machard D; Muhlethaler M; Jones BE
    Neuroscience; 2005; 130(4):807-11. PubMed ID: 15652980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of hypocretin neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Sandroni P; Low PA; Parisi JE
    Acta Neuropathol; 2007 Jan; 113(1):75-80. PubMed ID: 17089135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism.
    Peever JH; Lai YY; Siegel JM
    J Neurophysiol; 2003 May; 89(5):2591-600. PubMed ID: 12611960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.